Literature DB >> 33386105

Comparison of laparoscopic and open pancreaticoduodenectomy for the treatment of nonpancreatic periampullary adenocarcinomas: a propensity score matching analysis.

Chao Dang1, Min Wang1, Feng Zhu1, Tingting Qin2, Renyi Qin3.   

Abstract

BACKGROUND: Use of laparoscopic pancreaticoduodenectomy (LPD) in place of open pancreaticoduodenectomy (OPD) remains controversial. Our aim was to evaluate the results of LPD versus OPD in non-pancreatic periampullary adenocarcinoma (NPPC), a less aggressive tumor.
METHODS: Here, 488 NPPC patients who underwent LPD or OPD were analyzed in this study. The propensity score matching was used to balance the patients in two groups. Statistical analysis was conducted to investigate the differences between LPD and OPD in patients with NPPC.
RESULTS: The LPD group had shorter operative time, less intraoperative bleeding, and less postoperative hospital stay than OPD group. The 30- and 90-day mortality rates were significantly lower in LPD than in OPD group. There was no statistical difference in long-term survival between the two groups.
CONCLUSIONS: For NPPC, LPD may be the preferred surgical treatment due to its advantages over OPD in terms of intraoperative blood loss and short-term mortality.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Laparoscopic pancreaticoduodenectomy; Nonpancreatic periampullary adenocarcinoma; Open pancreaticoduodenectomy; Prognosis; Propensity score matching

Year:  2020        PMID: 33386105     DOI: 10.1016/j.amjsurg.2020.12.023

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  Assessment of the Ecological Protection Effectiveness of Protected Areas Using Propensity Score Matching: A Case Study in Sichuan, China.

Authors:  Zhifeng Zhang; Yuping Tang; Hongyi Pan; Caiyi Yao; Tianyi Zhang
Journal:  Int J Environ Res Public Health       Date:  2022-04-18       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.